RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Panion & BF Biotech Stock

Panion & BF Biotech ROA 2024

Panion & BF Biotech ROA

0.02

Ticker

1760.TW

ISIN

TW0001760007

In 2024, Panion & BF Biotech's return on assets (ROA) was 0.02, a -59.51% increase from the 0.06 ROA in the previous year.

Panion & BF Biotech Aktienanalyse

What does Panion & BF Biotech do?

Panion & BF Biotech Inc. is a Canadian company in the field of biotechnology. The company was founded in 2011 and has its headquarters in Vancouver, British Columbia. Panion & BF Biotech Inc. is listed on the Korean Stock Exchange and has offices in Korea and Hong Kong. The history of Panion & BF Biotech Inc. began when the company was founded by a group of experts in the field of biotechnology to develop innovative solutions that promote animal health and improve agricultural production. In recent years, the company has expanded its activities into various sectors and now offers a wide range of products and services tailored to the needs of animal owners and farmers. The business model of Panion & BF Biotech Inc. is based on the development and marketing of biotechnology products for animal health and agricultural production. The company also conducts research and development of new technologies and products aimed at increasing the efficiency of farmers and animal owners. Panion & BF Biotech Inc. works closely with universities and other research institutions to develop new product ideas. The company has various divisions, including the production of animal medicines, microorganisms, probiotics, and prebiotics, feed additives such as enzyme preparations, and urinary tract infection (UTI) tests. Panion & BF Biotech Inc. is also involved in the development of technologies such as gene editing and CRISPR/Cas9. The company also develops solutions to combat antibiotic resistance in livestock. In recent years, the company has developed and launched a number of products. One of these products is Aivlosin, an animal medicine used to treat respiratory diseases and infections in pigs and chickens. Aivlosin is also approved in North America and Europe. Another product from Panion & BF Biotech Inc. is the probiotic Smaart, which can improve the intestinal health of pigs and chickens. Panion & BF Biotech Inc. works closely with animal owners and farmers to understand their needs and develop products and services that help them overcome their challenges. The company has a broad customer base in various regions of the world, including North America, Europe, and Asia. Overall, Panion & BF Biotech Inc. has become a major player in the biotechnology industry. The company specializes in developing products that promote animal health and improve agricultural production. Panion & BF Biotech Inc. is committed to further investing in research and development of new technologies to meet the needs of animal owners and farmers. Panion & BF Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Panion & BF Biotech's Return on Assets (ROA)

Panion & BF Biotech's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Panion & BF Biotech's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Panion & BF Biotech's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Panion & BF Biotech’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Panion & BF Biotech stock

What is the Return on Assets (ROA) of Panion & BF Biotech this year?

The Return on Assets (ROA) of Panion & BF Biotech is 0.02 undefined this year.

What was the ROA of Panion & BF Biotech compared to the previous year?

The ROA of Panion & BF Biotech has increased by -59.51% compared to the previous year.

What consequences do high ROA have for investors of Panion & BF Biotech?

A high ROA is advantageous for investors of Panion & BF Biotech, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Panion & BF Biotech?

A low ROA can be unfavorable for investors of Panion & BF Biotech as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Panion & BF Biotech affect the company?

An increase in ROA of Panion & BF Biotech can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Panion & BF Biotech impact the company?

A reduction in the ROA of Panion & BF Biotech can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Panion & BF Biotech?

Some factors that can influence the ROA of Panion & BF Biotech include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Panion & BF Biotech important for investors?

The ROA of Panion & BF Biotech is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Panion & BF Biotech take to improve ROA?

To improve ROA, Panion & BF Biotech can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Panion & BF Biotech pay?

Over the past 12 months, Panion & BF Biotech paid a dividend of 2 TWD . This corresponds to a dividend yield of about 2.13 %. For the coming 12 months, Panion & BF Biotech is expected to pay a dividend of 2 TWD.

What is the dividend yield of Panion & BF Biotech?

The current dividend yield of Panion & BF Biotech is 2.13 %.

When does Panion & BF Biotech pay dividends?

Panion & BF Biotech pays a quarterly dividend. This is distributed in the months of July, July, August, July.

How secure is the dividend of Panion & BF Biotech?

Panion & BF Biotech paid dividends every year for the past 10 years.

What is the dividend of Panion & BF Biotech?

For the upcoming 12 months, dividends amounting to 2 TWD are expected. This corresponds to a dividend yield of 2.13 %.

In which sector is Panion & BF Biotech located?

Panion & BF Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Panion & BF Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Panion & BF Biotech from 7/10/2024 amounting to 1.5 TWD, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.

When did Panion & BF Biotech pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Panion & BF Biotech in the year 2023?

In the year 2023, Panion & BF Biotech distributed 1.5 TWD as dividends.

In which currency does Panion & BF Biotech pay out the dividend?

The dividends of Panion & BF Biotech are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Panion & BF Biotech

Our stock analysis for Panion & BF Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Panion & BF Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.